Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Recommendation of “Hold” from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $28.6923.

Several brokerages recently weighed in on ACHC. Cantor Fitzgerald raised their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Guggenheim upped their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. TD Cowen increased their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target on the stock in a report on Monday, May 4th.

Institutional Trading of Acadia Healthcare

A number of large investors have recently made changes to their positions in the stock. Wellington Management Group LLP raised its holdings in shares of Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. UBS Group AG grew its position in Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after purchasing an additional 350,484 shares during the period. Jefferies Financial Group Inc. purchased a new stake in Acadia Healthcare during the 4th quarter valued at $47,960,000. Finally, Invenomic Capital Management LP lifted its holdings in shares of Acadia Healthcare by 71.0% during the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after buying an additional 1,375,647 shares during the period.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $34.51 on Friday. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $35.83. The firm’s 50-day moving average is $27.64 and its 200 day moving average is $23.18. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -2.82, a PEG ratio of 11.34 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. Acadia Healthcare’s revenue was up 7.6% compared to the same quarter last year. During the same period last year, the business earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts anticipate that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.